Kayıhan KARAMAN, Ömer ATEŞ, Ataç ÇELİK, Metin KARAYAKALI, İlker AKAR, Fatih KOÇ, Fatih ALTUNKAŞ, İlker İNCE, Köksal CEYHAN, Murat YALÇIN, Mustafa ÖZÇETİN

Analyses of C-Reactive Protein, Endothelial Nitric Oxide Synthase and Interleukin-6 Gene Polymorphisms in Adolescents with a Family History of Premature Coronary Artery Disease: A Pilot Study

Background: Family history of premature atheroscle-rosis imposes a high risk to people. The relationship between atherosclerosis and gene polymorphisms of various biomarkers such as Endothelial Nitric Oxide Synthase (eNOS), C-Reactive Protein (CRP), and In-terleukin-6 (IL-6) has shown in previous studies.Aims: The major aim of the study was to evaluate the CRP, eNOS, and IL-6 gene polymorphisms in a group of adolescents who have a parental history of early cor-onary artery disease (CAD).Study Design: Case-control study.Methods: Thirty-six volunteers with a father with obstructive CAD during the first four decades and 46 subjects with a father with normal coronary arteries documented with coronary angiography were includ-ed in the study. Polymerase chain reaction-restriction fragment length polymorphism techniques were used to analyze CRP, eNOS, and IL-6 polymorphisms.Results: We did not find any differences between the two groups with regard to age, sex, body mass index, renal func-tions, systolic and diastolic blood pressures, lipid profile, and fasting glucose, hemoglobin, and high sensitivity CRP. A significant difference was only observed in IL-6-572 G/C genotype distribution and allele frequency between two groups (Pc=0.036 OR=3.48 CI (95%) 1.17-10.32).Conclusion: The present study showed a significant association between the IL-6-572 G/C gene polymor-phism (presence of C allele) and adolescents with a pa-rental history of premature CAD

PDF

___

Najjar SS, Scuteri A, Lakatta EG. Arterial aging: is it an immu- table cardiovascular risk factor? Hypertension 2005;46:454-62.
Stary HC. Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults. Arteriosclero- sis 1989;9:I19-32.
De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, et al; European Society of Cardiol- ogy Committee for Practice Guidelines. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Preven- tion in Clinical Practice. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Preven- tion in Clinical Practice. Eur Heart J 2003;24:1601-10.
Virani SS, Polsani VR, Nambi V. Novel markers of inflamma- tion in atherosclerosis. Curr Atheroscler Rep 2008;10:164-70.
Kampoli AM, Tousoulis D, Antoniades C, Siasos G, Stefanadis C. Biomarkers of premature atherosclerosis. Trends Mol Med 2009;15:23-32.
Tousoulis D, Kampoli AM, Papageorgiou N, Androulakis E, An- toniades C, Toutouzas K, et al. Pathophysiology of atheroscle- rosis: the role of inflammation. Curr Pharm Des 2011;17:4089- 110.
Mani A, Radhakrishnan J, Wang H, Mani A, Mani MA, Nelson- Williams C, et al. LRP6 mutation in a family with early coronary disease and metabolic risk factors. Science 2007;315:1278-82.
Mayer B, Erdmann J, Schunkert H. Genetics and heritability of coronary artery disease and myocardial infarction. Clin Res Car- diol 2007;96:1-7.
Urbina EM, Williams RV, Alpert BS, Collins RT, Daniels SR, Hayman L, et al; for the American Heart Association Athero- sclerosis, Hypertension and Obesity in Youth Committee of the Council on Cardiovascular Disease in the Young. Noninvasive assessment of subclinical atherosclerosis in children and ado- lescents: recommendations for standard assessment for clinical research: a scientific statement from the American Heart Asso- ciation. Hypertension 2009;54:919-50.
Celik A, Ozcetin M, Celikyay ZR, Sogut E, Yerli Y, Kadi H, et al. Evaluation of possible subclinical atherosclerosis in adoles- cents with a family history of premature atherosclerosis. Athero- sclerosis 2012;222:537-40.
McDade TW, Hawkley LC, Cacioppo JT. Psychological and be- havioral predictors of inflammation in middle-aged and older adults: The Chicago Health, Aging, and Social Relations Study. Psychosom Med 2006;68:376-81.
Andresdottir MB, Sigurdsson G, Sigvaldason H, Gudnason V. Fifteen percent of myocardial infarctions and coronary revas- cularizations explained by family history unrelated to conven- tional risk factors. The Reykjavik Cohort Study. Eur Heart J 2002;23:1655-63.
Ciftdogan DY, Coskun S, Ulman C, Tikiz H. The factor V G1691A, factor V H1299R, prothrombin G20210A polymor- phisms in children with family history of premature coronary artery disease. Coron Artery Dis 2009;20:435-9.
Yan M, Zhao L, Zheng F, Sun X, Zhang Y, Wang C. The rela- tionship between gene polymorphism and CRP level in a Chi- nese Han population. Biochem Genet 2007;45:1-9.
Brull DJ, Serrano N, Zito F, Jones L, Montgomery HE, Rumley A, et al. Human CRP gene polymorphism influences CRP lev- els: implications for the prediction and pathogenesis of coronary heart disease. Arterioscler Thromb Vasc Biol 2003;23:2063-9.
Wang L, Lu X, Li Y, Li H, Chen S, Gu D. Functional analy- sis of the C-reactive protein (CRP) gene -717A>G polymor- phism associated with coronary heart disease. BMC Med Genet 2009;10:73.
Akbarzadeh Najar R, Ghaderian SM, Tabatabaei Panah AS. C- reactive protein(CRP) gene polymorphisms: implication in CRP plasma levels and susceptibility to acute myocardial infarction. Mol Biol Rep 2012;39:3705-12.
Hermann M, Fischer D, Hoffmann MM, Gasser T, Quitzau K, Meinertz T, et al. CRP and CD14 polymorphisms correlate with coronary plaque volume in patients with coronary artery disease--IVUS substudy of the ENCORE trials. Atherosclerosis 2012;220:172-6.
Abd El-Aziz TA, Mohamed RH. Human C-reactive protein gene polymorphism and metabolic syndrome are associated with pre- mature coronary artery disease. Gene 2013;532:216-21.
Giacconi R, Cipriano C, Albanese F, Boccoli G, Saba V, Olivieri F, et al. The 174G/C polymorphism of IL-6 is useful to screen old subjects at risk for atherosclerosis or to reach successful age- ing. Exp Gerontol 2004;39:621-8.
Brull DJ, Montgomery HE, Sanders J, Dhamrait S, Luong L, Rumley A, et al. Interleukin-6 gene -174G/C and -572G/C pro- moter polymorphisms are strong predictors of plasma interleu- kin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol 2001;21:1458-63.
Aker S, Bantis C, Reis P, Kuhr N, Schwandt C, Grabensee B, et al. Influence of interleukin-6 G-174C gene polymorphism on coronary artery disease, cardiovascular complications and mortality in dialysis patients. Nephrol Dial Transplant 2009;24:2847-51.
Phulukdaree A, Khan S, Ramkaran P, Govender R, Moodley D, Chuturgoon AA. The interleukin-6 -147 g/c polymorphism is associated with increased risk of coronary artery disease in young South African Indian men. Metab Syndr Relat Disord 2013;11:205-9.
Maitra A, Shanker J, Dash D, John S, Sannappa PR, Rao VS, et al. Polymorphisms in the IL6 gene in Asian Indian families with premature coronary artery disease--the Indian Atherosclerosis Research Study. Thromb Haemost 2008;99:944-50.
Sekuri C, Cam FS, Sagcan A, Ercan E, Tengiz I, Alioglu E, et al. No association of interleukin-6 gene polymorphism (-174 G/C) with premature coronary artery disease in a Turkish cohort. Coron Artery Dis 2007;18:333-7.
Milutinovi? A, Hruskovicova H. The eNOS gene polymorphism does not have a major impact on lipid parameters and premature coronary artery disease in Slovene men (Caucasians). Folia Biol (Praha) 2005;51:47-9.
Ekmekçi A, Uluganyan M, Gungör B, Abacı N, Ozcan KS, Ertaş G, et al. Association between endothelial nitric oxide synthase intron 4a/b polymorphism and aortic dissection. Turk Kardiyol Dern Ars 2014;42:55-60.
Cam SF, Sekuri C, Tengiz I, Ercan E, Sagcan A, Akin M, et al. The G894T polymorphism on endothelial nitric oxide synthase gene is associated with premature coronary artery disease in a Turkish population. Thromb Res 2005;116:287-92.
Ekmekçi A, Ozcan KS, Güngör B, Abaci N, Osmonov D, Ze- ncirci A, et al. The relationship between endothelial nitric oxide synthase 4a/4b gene polymorphism and premature coronary ar- tery disease. Acta Cardiol 2013;68:464-8.